Pursuing Excellence in Xeno, Shaping Swine into Life-Giving Vessels, Sowing Blessings Across Humanity

Pursuing Excellence in Xeno, Shaping Swine into Life-Giving Vessels, Sowing Blessings Across Humanity

Millions wait for transplants — together, we can bring hope to life

Millions wait for transplants — together, we can bring hope to life

What is Xenotransplantation?

Concept

Transplanting animal-derived organs, tissues, or cells into humans


Types

Solid organs (e.g., kidney, liver, heart), biological tissues, and cellular therapies


Core Value

Addressing the critical global shortage of transplantable human organs

What is Xenotransplantation?
Why Choose Pigs for Xenotransplantation?

Pigs are considered ideal organ donors for xenotransplantation

  • Comparable organ size, and physiological compatibility with humans

  • High genetic tractability and rapid reproductive cycle

  • Lower ethical concerns compared to non-human primates, with manageable risk of zoonotic disease transmission

  • Well-established husbandry practices ensure a stable and reliable medical-grade organ supply

Why Choose Pigs for Xenotransplantation?
About ClonOrgan
China's Leading Xenotransplantation Enterprise

ClonOrgan is long-term dedicated to the in-depth R&D of xenotransplantation donor pigs;

Cultivating China's largest population of gene-edited, low-immunogenicity donor pigs;

Developing therapeutic technologies using transplantable pig organs and tissues, including kidneys, livers, hearts, skin, red blood cells.

  • Professor Dengke Pan

    Professor Dengke Pan

  • Professor Shaoping Deng

    Professor Shaoping Deng

News
Company News
Media Coverage
Science Outreach
Science Literature
  • 中科奥格独家供应原材料的国内首个SPF级猪源胶原蛋白植入剂获批上市

    2026/01/15 Company News
    近日,由中科奥格独家供应原材料、成都奇璞生物科技有限公司自主研发的国产首个SPF级猪源胶原植入剂,正式获得国家药品监督管理局(NMPA)批准上市,注册证编号:国械注准20263130023。这标志着我国在高端生物医用材料领域实现重大突破,成功填补国内SPF级猪源生物材料空白,打破了对进口原料的长期依赖。什么是SPF级猪?医疗级“安全猪”的硬核标准不同于普通养殖的生猪,SPF级猪(无特定病原体猪)是...
  • 走上临床!2025中科奥格大事记

    2026/01/04 Company News
    导语2025年,全球异种移植迎来历史性跨越。美国2个团队获批开展异种肾移植临床试验,中国团队也进入异种移植临床研究。作为中国异种移植领军企业,中科奥格取得了丰硕的成果,让我们一起盘点2025中科奥格大事记。01 《Science》年度十大突破,6基因编辑猪成果被引用2025年12月,国际顶级学术期刊《Science》发布全球2025年度十大科学突破,异种移植入选:美国一例经69处基因改造...